We are live on ! Find out more
OREX

Orexigen Therapeutics, Inc.
OREX

Delisted

OREX was delisted on the 3rd of April, 2018.

Back to rankings

123 hedge funds and large institutions have $442M invested in Orexigen Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 123 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more call options, than puts

Call options by funds: $10.4M | Put options by funds: $6.53M

Holders
123
Holders Change
+123
Holders Change %
–
% of All Funds
4.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
123
Increased
–
Reduced
–
Closed
–
Calls
$10.4M
Puts
$6.53M
Net Calls
+$3.87M
Net Calls Change
+$3.87M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$5.06M +$5.33M +86,570 New
Jennison Associates
27
Jennison Associates
New York
$4.89M +$5.14M +83,559 New
MCM
28
Montibus Capital Management
Oregon
$4.78M +$5.04M +81,858 New
TA
29
Teachers Advisors
New York
$4.54M +$4.78M +77,642 New
PC
30
Passport Capital
California
$4.38M +$4.61M +75,000 New
TAM
31
Tiverton Asset Management
Delaware
$4.09M +$4.31M +70,000 New
Citigroup
32
Citigroup
New York
$4.02M +$4.23M +68,749 New
JP Morgan Chase
33
JP Morgan Chase
New York
$3.82M +$4.02M +65,345 New
EIM
34
Essex Investment Management
Massachusetts
$3.59M +$3.77M +61,356 New
Principal Financial Group
35
Principal Financial Group
Iowa
$2.99M +$3.15M +51,145 New
Allianz Asset Management
36
Allianz Asset Management
Germany
$2.92M +$3.08M +50,050 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
$2.87M +$3.02M +49,117 New
TCIM
38
TIAA CREF Investment Management
New York
$2.74M +$2.88M +46,874 New
Geode Capital Management
39
Geode Capital Management
Massachusetts
$2.13M +$2.24M +36,425 New
Wells Fargo
40
Wells Fargo
California
$2.05M +$2.16M +35,103 New
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$1.97M +$2.07M +33,582 New
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$1.95M +$2.05M +33,347 New
DCM
43
Driehaus Capital Management
Illinois
$1.94M +$2.04M +33,214 New
GC
44
Guggenheim Capital
Illinois
$1.82M +$1.92M +31,166 New
JCG
45
JHL Capital Group
Illinois
$1.75M +$1.85M +30,000 New
SCA
46
SAC Capital Advisors
Connecticut
$1.64M +$1.72M +28,000 New
Hudson Bay Capital Management
47
Hudson Bay Capital Management
Connecticut
$1.46M +$1.54M +25,000 New
BIM
48
BlackRock Investment Management
Delaware
$1.46M +$1.54M +24,995 New
KIA
49
Kopp Investment Advisors
Minnesota
$1.25M +$1.31M +21,375 New
AQR Capital Management
50
AQR Capital Management
Connecticut
$1.22M +$1.28M +20,827 New
1
2
3 4 5

OREX Hedge Fund Activity: Q2 2013 in Review

123 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Orexigen Therapeutics, Inc. (OREX) for Q2 2013, worth a combined $442M.

Buyers outnumbered sellers: 123 funds opened new OREX positions and 0 closed out — a net gain of 123 holders — while 0 added to existing stakes and 0 trimmed.

  • 123 institutional investors held Orexigen Therapeutics, Inc. (OREX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $442M of Orexigen Therapeutics, Inc. stock for Q2 2013.
  • 123 funds opened new Orexigen Therapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +123 holders.

Based on aggregated 13F filings for Q2 2013.